Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heddle

Showing results (501-510 of 581) with videos related to

Pageof 59
Sort By:
Environmental and Molecular Mutagenesis|March 29, 2000
In vivo transgenic mutation assaysJ A Heddle, S Dean, T Nohmi, et al.
Mutation Research|October 11, 2003
In vivo transgenic mutation assaysVéronique Thybaud, Stephen Dean, Takehiko Nohmi, et al.
Blood Advances|November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopeniaManraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Nature Catalysis|February 6, 2023
Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidinElizabeth Michalczyk, Kay Hommernick, Iraj Behroz, et al.
Transfusion|January 31, 2026
Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes studyS Ning, N Li, Y Liu, et al.
Thrombosis Research|August 4, 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort studyJason B Giles, Jerome Rollin, Kiana L Martinez, et al.
Thrombosis and Haemostasis|January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and RationaleDonald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Plos One|August 2, 2014
Phage ORF family recombinases: conservation of activities and involvement of the central channel in DNA bindingFiona A Curtis, Ali D Malay, Alexander J Trotter, et al.
Transfusion|February 7, 2024
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCERena Buckstein, Jeannie Callum, Anca Prica, et al.
Blood|January 7, 2012
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopeniaDonald M Arnold, Nancy M Heddle, Julie Carruthers, et al.
Pageof 59

Showing results (501-510 of 581) with videos related to

Sort By:
Pageof 59
Environmental and Molecular Mutagenesis|March 29, 2000
In vivo transgenic mutation assaysJ A Heddle, S Dean, T Nohmi, et al.
Mutation Research|October 11, 2003
In vivo transgenic mutation assaysVéronique Thybaud, Stephen Dean, Takehiko Nohmi, et al.
Blood Advances|November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopeniaManraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Nature Catalysis|February 6, 2023
Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidinElizabeth Michalczyk, Kay Hommernick, Iraj Behroz, et al.
Transfusion|January 31, 2026
Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes studyS Ning, N Li, Y Liu, et al.
Thrombosis Research|August 4, 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort studyJason B Giles, Jerome Rollin, Kiana L Martinez, et al.
Thrombosis and Haemostasis|January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and RationaleDonald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Plos One|August 2, 2014
Phage ORF family recombinases: conservation of activities and involvement of the central channel in DNA bindingFiona A Curtis, Ali D Malay, Alexander J Trotter, et al.
Transfusion|February 7, 2024
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCERena Buckstein, Jeannie Callum, Anca Prica, et al.
Blood|January 7, 2012
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopeniaDonald M Arnold, Nancy M Heddle, Julie Carruthers, et al.
Pageof 59